Alnylam Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF PROTEIN C (PROC) GENES
Last updated:
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) targeting a PROC gene, and methods of using the dsRNA to inhibit expression of PROC.
Status:
Application
Type:
Utility
Filling date:
27 Jul 2021
Issue date:
16 Dec 2021